Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular biomarkers in early stage lung cancer
M. Fernández Rodríguez, Daniel Ajona, Luis Seijó, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 2, pp. 1165-1185
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Extracellular Vesicles as Biomarkers and Therapeutic Tools: From Pre-Clinical to Clinical Applications
Maria Chiara Ciferri, Rodolfo Quarto, Roberta Tasso
Biology (2021) Vol. 10, Iss. 5, pp. 359-359
Open Access | Times Cited: 145
Lung Cancer Screening in Asia: An Expert Consensus Report
David Lam, Chong Kin Liam, Sita Andarini, et al.
Journal of Thoracic Oncology (2023) Vol. 18, Iss. 10, pp. 1303-1322
Closed Access | Times Cited: 54
Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
Hafiza Padinharayil, Jinsu Varghese, Mithun Chacko John, et al.
Genes & Diseases (2022) Vol. 10, Iss. 3, pp. 960-989
Open Access | Times Cited: 68
Feature selection methods and predictive models in CT lung cancer radiomics
Gary Ge, Jie Zhang
Journal of Applied Clinical Medical Physics (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 39
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia
Tetsuya Mitsudomi, Daniel S.W. Tan, James Chih‐Hsin Yang, et al.
Journal of Thoracic Oncology (2022) Vol. 18, Iss. 4, pp. 436-446
Open Access | Times Cited: 31
Revolutionizing Cancer Detection: Harnessing Quantum Dots and Graphene-Based Nanobiosensors for Lung and Breast Cancer Diagnosis
Soheil Sadr, Abbas Rahdar, Sadanand Pandey, et al.
BioNanoScience (2024) Vol. 15, Iss. 1
Closed Access | Times Cited: 6
The Role of Biomarkers in Lung Cancer Screening
Efimia Boutsikou, Georgia Hardavella, Eleni Fili, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1980-1980
Open Access | Times Cited: 5
Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers
Elizabeth Córdoba-Lanús, Luis M. Montuenga, Angélica Domínguez-de-Barros, et al.
Antioxidants (2024) Vol. 13, Iss. 2, pp. 156-156
Open Access | Times Cited: 4
Biosensors as emerging tools in cancer theranostics: Recent progress
Bhabani Sankar Satapathy, Abhishek Mishra, Subhrajit Behera, et al.
Elsevier eBooks (2025), pp. 17-28
Closed Access
A Thorough Review of the Clinical Applications of Artificial Intelligence in Lung Cancer
Serafeim‐Chrysovalantis Kotoulas, Dionysios Spyratos, Κonstantinos Porpodis, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 882-882
Open Access
Low-Abundance Protein Enrichment for Medical Applications: The Involvement of Combinatorial Peptide Library Technique
Egisto Boschetti, Pier Giorgio Righetti
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10329-10329
Open Access | Times Cited: 9
New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insights
Mauro Buono, Gianluca Russo, Valerio Nardone, et al.
The Journal of Liquid Biopsy (2024) Vol. 5, pp. 100153-100153
Open Access | Times Cited: 3
NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target
Hongbo Huang, Qingwang Hua
International Journal of Genomics (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 12
Kruppel like factor 16 promotes lung adenocarcinoma progression by upregulating lamin B2
Xiaodan Jiao, Weinian Gao, Hongxin Ren, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 9483-9495
Open Access | Times Cited: 11
Personalized medicine: Clinical oncology on molecular view of treatment
Rafick Costa Dos Santos Da Silva, Nathalia de Andrade Simon, André Alves Dos Santos, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 8, pp. 992-1001
Open Access | Times Cited: 2
Benign‐malignant classification of pulmonary nodules by low‐dose spiral computerized tomography and clinical data with machine learning in opportunistic screening
Yansong Zheng, Jing Dong, Xue Yang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 11, pp. 12050-12064
Open Access | Times Cited: 6
GZ17-6.02 and Pemetrexed Interact to Kill Osimertinib-Resistant NSCLC Cells That Express Mutant ERBB1 Proteins
Laurence Booth, Cameron West, Robert P. Moore, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13
The role of lamin B2 in human diseases
Yuxuan Li, Jie Zhu, Zongdong Yu, et al.
Gene (2023) Vol. 870, pp. 147423-147423
Closed Access | Times Cited: 5
Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011−2021
Jessie T. Yan, Yue Jin, Ernest Lo, et al.
Oncology and Therapy (2023) Vol. 11, Iss. 3, pp. 343-360
Open Access | Times Cited: 5
Use of adjuvant chemotherapy in resected non-small cell lung cancer in real-life practice: a systematic review of literature
Anne-Laure Désage, Wafa Bouleftour, Olivier Tiffet, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 12, pp. 4643-4665
Open Access | Times Cited: 12
MiRNAs and snoRNAs in Bone Metastasis: Functional Roles and Clinical Potential
Margherita Puppo, Mariam Jaafar, Jean‐Jacques Diaz, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 242-242
Open Access | Times Cited: 8
Clinical Scores, Biomarkers and IT Tools in Lung Cancer Screening—Can an Integrated Approach Overcome Current Challenges?
Wieland Voigt, Helmut Prosch, Mario Silva
Cancers (2023) Vol. 15, Iss. 4, pp. 1218-1218
Open Access | Times Cited: 4
Clinical role of serum tumor markers SCC, NSE, CA 125, CA 19-9, and CYFRA 21-1 in patients with lung cancer
Aiwen Sun
Laboratory Medicine (2023) Vol. 54, Iss. 6, pp. 638-645
Closed Access | Times Cited: 4
Genomic landscape and tumor mutational features of resected preinvasive to invasive lung adenocarcinoma
Yangui Lin, Dan Li, Hongliang Hui, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top